Quarter And Nine Months Ended On 31St December 2024.
Filed with BSE · · 3 pages · English
Date: 20.01.2025 Sub: Outcome of the Board Meeting held on 20th January 2025 1) The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024. The meeting of the Board of Directors commenced
Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held On 20Th January 2025.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Rekvina Laboratories Ltd. Press Release Jan 13 2025
- Board Meeting Intimation for Board Meeting To Be Held On 20Th January, 2025.
- Reply With Respect To Reason For Delay Submission Of Information Regarding Resignation Of Chief Financial Officer To The Exchange Within 24 Hours From The Effective Date Of Resignation.
Later from Rekvina Laboratories
- Integrated Filing (Financial)
- Rekvina Laboratories Ltd. Press Release Jan 30 2025
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Rekvina Laboratories Ltd. Press Release Feb 18 2025
- Rekvina Laboratories Ltd. Press Release Feb 21 2025
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories